Surrogate Endpoints Acceptable in AML Trials, Says FDA
In the case of drugs used for newly diagnosed acute myeloid leukemia (AML), surrogate endpoints have been validated, says the US Food and Drug Administration.
Source: medscape.com
Daniel Pollyea News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Daniel Pollyea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Daniel Pollyea Today - Breaking & Trending Today